This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Stock picking requires research and discipline; assess whether your time, resources, and goals justify active selection over passive options.
17,093 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Political rhetoric can shake markets and impact wallets. This article breaks down how trump’s “election integrity arm...
As the Q1 2026 earnings transcript approaches, investors look for how Millicom will balance growth across mobile serv...
Bank of America raises Coherent's price target to $400 on a larger AI data center market forecast, keeping a Neutral ...
Could Ethereum reach $5,000 by 2030? This article breaks down the logic, the timing, and practical steps you can take...
A notable stake reduction by pacific ridge capital trims its NWPX position, signaling a shift in exposure. This guide...
A routine ethics filing has become a focal point for investors and policymakers. This deep dive explains what the qua...
Beam Global is shaping the clean-energy charging space. In this piece, we break down what Q1 2026 earnings might reve...
Home Depot says customers remain healthy, but big-ticket remodeling and discretionary purchases are cooling in pocket...
Wells Fargo and Oppenheimer boosted Marvell targets this week, signaling rising confidence in AI infrastructure deman...
The SonicShares Global Shipping ETF BOAT surged 51% over the past year, yet its quarterly payouts remain highly volat...
A leading U.S. health care powerhouse is quietly building an AI-driven engine that touches every corner of its busine...